Total Payments
$596,340
2024 Payments
$19,356
Companies
16
Transactions
357
Medicare Patients
526
Medicare Billing
$60,157
Payment Breakdown by Category
Other$357,267 (59.9%)
Consulting$158,804 (26.6%)
Travel$67,673 (11.3%)
Food & Beverage$8,572 (1.4%)
Research$4,025 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $357,267 | 113 | 59.9% |
| Consulting Fee | $158,804 | 39 | 26.6% |
| Travel and Lodging | $67,673 | 88 | 11.3% |
| Food and Beverage | $8,572 | 114 | 1.4% |
| Unspecified | $4,025 | 3 | 0.7% |
Payments by Type
General
$592,315
354 transactions
Research
$4,025
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $389,642 | 225 | $0 (2022) |
| Genentech USA, Inc. | $73,257 | 51 | $0 (2024) |
| F. Hoffmann-La Roche AG | $70,089 | 34 | $0 (2019) |
| GENZYME CORPORATION | $25,166 | 9 | $0 (2023) |
| GlaxoSmithKline, LLC. | $18,913 | 17 | $0 (2024) |
| Hoffmann-La Roche Limited | $9,120 | 5 | $0 (2018) |
| Celgene Corporation | $3,065 | 3 | $0 (2020) |
| Eli Lilly and Company | $2,125 | 3 | $0 (2021) |
| ABBVIE INC. | $1,725 | 1 | $0 (2024) |
| Shionogi Inc | $1,110 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,356 | 20 | GlaxoSmithKline, LLC. ($14,363) |
| 2023 | $8,427 | 3 | GlaxoSmithKline, LLC. ($4,550) |
| 2022 | $5,420 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($5,420) |
| 2021 | $49,566 | 23 | Boehringer Ingelheim Pharmaceuticals, Inc. ($38,600) |
| 2020 | $55,346 | 37 | Boehringer Ingelheim Pharmaceuticals, Inc. ($52,011) |
| 2019 | $126,286 | 69 | Boehringer Ingelheim Pharmaceuticals, Inc. ($94,378) |
| 2018 | $132,618 | 89 | Boehringer Ingelheim Pharmaceuticals, Inc. ($107,505) |
| 2017 | $199,322 | 114 | Boehringer Ingelheim Pharmaceuticals, Inc. ($91,728) |
All Payment Transactions
357 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/10/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,725.00 | General |
| 06/05/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $11,290.57 | General |
| 05/23/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $619.57 | General |
| 05/23/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $307.15 | General |
| 05/23/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $35.31 | General |
| 05/22/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $894.02 | General |
| 05/22/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $382.30 | General |
| 05/22/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $184.42 | General |
| 05/22/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $106.96 | General |
| 05/22/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $90.24 | General |
| 05/22/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $82.93 | General |
| 05/22/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $22.99 | General |
| 05/22/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $22.19 | General |
| 05/22/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $18.29 | General |
| 05/22/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $18.29 | General |
| 05/21/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $184.42 | General |
| 05/21/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $103.20 | General |
| 01/19/2024 | Medtronic, Inc. | SIGNIA (Device) | Food and Beverage | In-kind items and services | $97.04 | General |
| Category: Surgical Stapling | ||||||
| 01/03/2024 | Genentech USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| 01/03/2024 | Genentech USA, Inc. | — | Travel and Lodging | Cash or cash equivalent | $890.65 | General |
| 12/14/2023 | Genentech, Inc. | — | Food and Beverage | In-kind items and services | $142.04 | General |
| 10/27/2023 | GENZYME CORPORATION | CERDELGA (Drug) | Consulting Fee | Cash or cash equivalent | $3,734.50 | General |
| Category: Genetic Disease | ||||||
| 07/05/2023 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $4,550.00 | General |
| 03/22/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,120.00 | General |
| 01/13/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| IPF-001 Phase 2 (CC-90001-IPF-001) (BMS Study Number: IM043-P04) (CC-90001-IPF-001) | Celgene Corporation | $1,800 | 1 |
| IPF-001 Phase 2 (CC-90001-IPF-001) (BMS Study Number: IM043-P04) | Celgene Corporation | $1,200 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 138 | 290 | $87,236 | $20,422 |
| 2022 | 2 | 98 | 243 | $52,803 | $12,684 |
| 2021 | 4 | 154 | 248 | $63,406 | $17,690 |
| 2020 | 3 | 136 | 197 | $42,896 | $9,361 |
Total Patients
526
Total Services
978
Medicare Billing
$60,157
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 73 | 195 | $42,444 | $9,455 | 22.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 12 | 33 | $23,760 | $5,970 | 25.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 30 | 30 | $14,172 | $3,355 | 23.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 23 | 32 | $6,860 | $1,642 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 64 | 183 | $39,720 | $9,557 | 24.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 34 | 60 | $13,083 | $3,127 | 23.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 62 | 116 | $33,113 | $9,590 | 29.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 40 | 69 | $12,823 | $3,518 | 27.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 41 | 52 | $11,033 | $2,981 | 27.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 11 | 11 | $6,437 | $1,601 | 24.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 54 | 85 | $21,760 | $4,965 | 22.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 43 | 60 | $12,452 | $2,622 | 21.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 39 | 52 | $8,684 | $1,774 | 20.4% |
About Dr. Paul Noble, MD
Dr. Paul Noble, MD is a Critical Care Medicine healthcare provider based in West Hollywood, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1942286307.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Noble, MD has received a total of $596,340 in payments from pharmaceutical and medical device companies, with $19,356 received in 2024. These payments were reported across 357 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($357,267).
As a Medicare-enrolled provider, Noble has provided services to 526 Medicare beneficiaries, totaling 978 services with total Medicare billing of $60,157. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location West Hollywood, CA
- Active Since 12/19/2005
- Last Updated 09/25/2020
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942286307
Products in Payments
- OFEV (Drug) $275,331
- Esbriet (Biological) $99,640
- SAR156597 (Drug) $13,866
- CERDELGA (Drug) $3,735
- CC-90001 (Drug) $1,800
- SIGNIA (Device) $97.04
- TECENTRIQ (Biological) $96.24
- TREPROSTINIL (Drug) $19.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in West Hollywood
Oren Friedman, Md, MD
Critical Care Medicine — Payments: $234,451
Critical Care Medicine $234,451
Jasminka Stegic, Np, NP
Critical Care Medicine — Payments: $10,827
Critical Care Medicine $10,827
Yelena Neyman, M.d, M.D
Critical Care Medicine — Payments: $302.36
Critical Care Medicine $302.36
Mehrnaz Hadian, Md, Ms, MD, MS
Critical Care Medicine — Payments: $213.97
Critical Care Medicine $213.97
Mrs. Katrina Harper-Kirksey, M.d, M.D
Critical Care Medicine — Payments: $150.00
Critical Care Medicine $150.00
Dr. Lucresia Montes, M.d, M.D
Critical Care Medicine — Payments: $113.78
Critical Care Medicine $113.78